TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma
Advanced Science · 2024
DOI: 10.1002/advs.202402578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhixuan Bian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Signal Transduction, Transcription Factors. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Group Project of Shanghai Municipal Health Commission, Key project of Shanghai "Science and Technology Innovation Action Plan".
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide. Significantly activated uridine nucleotide and fatty acid metabolism in HCC cells promote malignant proliferation and immune evasion. Herein, it is demonstrated that the tripartite motif 65 (TRIM65) E3 ubiquitin‐protein ligase, O‐GlcNAcylated via O‐GlcNAcylation transferase, is highly expressed in HCC and facilitated metabolic remodeling to promote the accumulation of products related to uracil metabolism and palmitic acid, driving the progression of HCC. Mechanistically, it is showed that TRIM65 mediates ubiquitylation at the K44 residue of neurofibromatosis type 2 (NF2), the key protein upstream of classical Hippo signaling. Accelerated NF2 degradation inhibits yes‐associated protein 1 phosphorylation, inducing aberrant activation of related metabolic enzyme transcription, and orchestrating metabolic and immune advantages. In conclusion, these results reveal a critical role for the TRIM family molecule TRIM65 in supporting HCC cell survival and highlight the therapeutic potential of targeting its E3 ligase activity to alter the regulation of proteasomal degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
- Faculty of Medical Laboratory Science, College of Health Science and Technology, School of Medicine, Shanghai jiao Tong University, Shanghai, 200025, China.
- Shanghai Key Laboratory of Clinical Molecular Diagnostics for Paediatrics, Shanghai, 200127, China.
- Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China.
- Department of liver surgery, Zhongshan hospital, Fudan University, Shanghai, 200030, China.
- Department of Central Laboratory, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China.
ORCID-Profile: Fenyong Sun
Förderung
- National Natural Science Foundation of China
- Innovation Group Project of Shanghai Municipal Health Commission
- Key project of Shanghai "Science and Technology Innovation Action Plan"
- Clinical Research Plan of Shanghai Hospital Development Center
Zitieren
APA
Bian, Z., Xu, C., Wang, X., Zhang, B., Xiao, Y., Liu, L., Zhao, S., Huang, N., Yang, F., Zhang, Y., Xue, S., Wang, X., Pan, Q., & Sun, F. (2024). TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202402578
Vancouver
Bian Z, Xu C, Wang X, Zhang B, Xiao Y, Liu L, et al. TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma. Advanced Science. 2024. doi:10.1002/advs.202402578
BibTeX
@article{Bian2024,
author = {Bian, Zhixuan and Xu, Chang and Wang, Xiaoying and Zhang, Baohua and Xiao, Yixuan and Liu, Li and Zhao, Shasha and Huang, Nan and Yang, Fengjiao and Zhang, Yue and Xue, Shaobo and Wang, Xiongjun and Pan, Qiuhui and Sun, Fenyong},
title = {TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202402578}
}
EUVIMED